Avadel Pharmaceuticals Plc [AVDL]

Source: 

Company Overview

Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company. Our lead product candidate, FT218, is an investigational once-nightly, extended-release formulation of sodium oxybate for the treatment of excessive daytime sleepiness (“EDS”) or cataplexy in adults with narcolepsy.